Physician profile
Mark R Mount
NPI 1811950264
$5,042.09
in general payments reported to CMS, 2019-2025
26 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,033 · 2020: $39.35 · 2021: $105 · 2022: $495 · 2023: $188 · 2024: $1,931 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,538 · Food and Beverage: $829 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,537.98 |
| Food and Beverage | $828.69 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $2,326.09 | 2019-2024 | Acclarent Aera |
| Medical Device Business Services, INC. | $1,227.45 | 2019 | |
| Intersect Ent, INC. | $252.59 | 2019-2022 | |
| Stryker Corporation | $221.08 | 2019-2023 | Scopis Ent |
| Glaxosmithkline, LLC. | $135.76 | 2022-2025 | Nucala |
| Optinose US, INC. | $129.59 | 2022-2024 | |
| Boston Scientific Corporation | $105.52 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $90.71 | 2022 | |
| Genzyme Corporation | $88.04 | 2019-2025 | |
| Axogen | $59.35 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Aerin Medical INC. | $56.94 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $38.36 | 2024-2025 | Dupixent |
| Smith+Nephew, INC. | $35.97 | 2022 | |
| Merck Sharp & Dohme LLC | $30.35 | 2023 | |
| Integra Lifesciences Corporation | $29.20 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $27.90 | 2023 | Fetroja |
| Ambu INC. | $24.14 | 2022 | |
| Polynovo North America LLC | $22.19 | 2024 | Novosorb Btm |
| Livanova USA, INC. | $20.61 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic USA, INC. | $20.50 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.42 | 2023 | Nuzyra |
| Astrazeneca Pharmaceuticals LP | $17.56 | 2025 | Tezspire |
| Davol INC. | $16.88 | 2019 | |
| Abbvie INC. | $16.33 | 2023 | |
| Novo Nordisk INC | $15.17 | 2022 | |
| Inspire Medical Systems, INC. | $13.39 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mount listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.